Insights Archive

Filter:

Read more

March 2021

Publication: Oxford Science Enterprise

Meet the Founders

Meet the Founders: Cheerag Shirodaria, CEO and Charalambos Antoniades, CSO, Caristo Diagnostics Cardiovascular disease is the world’s biggest killer, accounting…

Read more

March 2021

Publication: British Heart Foundation (BHF)

BHF researchers secure EU approval for new AI heart attack prediction technology

Research funded by us has led to EU-approved artificial intelligence (AI) technology that can identify people at high risk of…

Read more

March 2021

Publication: The Sunday Times

AI spots heart risk hidden on scans

The NHS is using new technology to warn patients most in danger of an attack — up to nine years…

Read more

February 2021

Publication: Cardiothoracic Imaging, Volume 3, Issue 1

Assessing Cardiovascular Risk by Using the Fat Attenuation Index in Coronary CT Angiography

Coronary CT angiography (CCTA) has evolved into a first-line diagnostic test for the investigation of chest pain. Despite advances toward…

Read more

February 2021

Publication: Medscape Brazil

Fat attenuation index (FAI): a paradigm shift in cardiology.

Medscape Brazil have featured Dr Cheerag Shirodaria for his work within the industry. Cheerag Shirodaria is a Cardiologist and Honorary…

Read more

February 2021

Publication: Physicians' Academy for Cardiovascular Education

Anti-Inflammation Heralds the Future of CV Medicine

From CANTOS to COLCOT to COPS to LoDoCo2: Dr. Ridker presents the lessons from these trials with anti-inflammatory treatment, in…

Read more

January 2021

Publication: European Heart Journal, Volume 42, Issue 7

The Year in Cardiovascular Medicine 2020: Digital Health and Innovation

Advances in digital health and particularly in artificial intelligence (AI) have led us very close to the true implementation of…

Read more

September 2020

Publication: Journal of the American collage of Cardiology

Current Evidence and Recommendations for Coronary CTA First in Evaluation of Stable Coronary Artery Disease

In the United States, functional imaging is the most commonly used method to diagnose potentially obstructive coronary artery disease (CAD) in patients…
  • Registered in England and Wales under company number 11429590
  • CaRi-Heart® is limited to investigational use in the United States.

All contents of this website are copyright 2018 - 2021 Caristo Diagnostics Ltd. All rights reserved. No content may be copied or reproduced without the express permission of Caristo Diagnostics Ltd.
All copyright, trade-marks, design rights, database rights, patents and other intellectual property rights (registered and unregistered) in and on this website are owned by Caristo Diagnostics Ltd. and/or certain third parties.